Publication

Article

CURE

Summer 2009
Volume8
Issue 2

Childhood Cancer Survivorship Programs

Childhood cancer survivors need long-term surveillance to keep up with late-term effects, screenings, and other health-related issues.

Childhood cancer survivors need lifelong follow-up care to monitor for secondary cancers, long-term and late effects, and other health-related issues. Below are a list of programs that provide survivorship care to childhood cancer survivors.

http://beyondthecure.org/resources/follow-up-clinics.html.

The National Children’s Cancer Society provides a listing of long-term follow-up clinics for survivors of childhood cancer at

Other Childhood Cancer Survivors Programs:

Children’s Hospital Los Angeles LIFE Program (Long-term Information, Follow-Up and Evaluation)

www.childrenshospitalla.org/site/c.ipINKTOAJsG/b.4347877/k.899B/LIFE_Program.htm

City of Hope Childhood Cancer Survivorship Program

www.cityofhope.org/survivorship

HEROS Clinic at Yale Cancer Center

www.med.yale.edu/pediat/hem_onc/heros/index.html

UCLA’s Jonsson Comprehensive Cancer Center Pediatric Long-Term Follow-Up Program

www.cancer.ucla.edu/Index.aspx?page=222

UCSF Survivors of Childhood Cancer Program

www.ucsfhealth.org/childrens/special/s/100903.html

University of Chicago Comer Children’s Hospital Childhood Cancer Survivors Center

www.uchicagokidshospital.org/specialties/cancer/survivors/index.html

UT Southwestern Medical Center and Children’s Medical Center in Dallas' After the Cancer Experience

www.childrens.com/ace

Related Videos
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of a woman with short brown hair, wearing glasses.
Image of a woman with brown shoulder-length hair, wearing a khaki colored blazer.
Image of a man wearing a black suit and tie.
Image of a man with rectangular glasses and a goatee.
Image of a woman with a brown hair tied into a bun.
Image of Dr. Jorge Cortes; a man with short dark hair wearing a suit.
Related Content